bioAffinity Technologies, Inc. (BIAFW) stock
BIAFWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 4/3056% below fair value
$0.24+0.00 (0.00%)
Close on Oct 30, 2026Market cap $23.58MP/E –Yield –
bioAffinity Technologies total assets
Total assets on the balance sheet at the end of each period.
bioAffinity Technologies's total assets was $7.62M at Jun 30, 2026. For fiscal 2025 it was $10.96M, up 68.3% from the year before. The highest annual figure on record is $12.18M in fiscal 2022.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.96M | +68.3% |
| FY2024 | Dec 31, 2024 | $6.51M | -20.8% |
| FY2023 | Dec 31, 2023 | $8.22M | -32.5% |
| FY2022 | Dec 31, 2022 | $12.18M | +738.2% |
| FY2021 | Dec 31, 2021 | $1.45M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.62M | +60.4% |
| Q1 FY2026 | Mar 31, 2026 | $7.95M | +43.2% |
| Q4 FY2025 | Dec 31, 2025 | $10.96M | +68.3% |
| Q3 FY2025 | Sep 30, 2025 | $11.55M | +76.2% |
| Q2 FY2025 | Jun 30, 2025 | $4.75M | -28.6% |
| Q1 FY2025 | Mar 31, 2025 | $5.55M | -31.1% |
| Q4 FY2024 | Dec 31, 2024 | $6.51M | -20.8% |
| Q3 FY2024 | Sep 30, 2024 | $6.55M | -35.7% |
| Q2 FY2024 | Jun 30, 2024 | $6.66M | -25.0% |
| Q1 FY2024 | Mar 31, 2024 | $8.05M | -23.1% |
| Q4 FY2023 | Dec 31, 2023 | $8.22M | -32.5% |
| Q3 FY2023 | Sep 30, 2023 | $10.19M | -27.5% |
| Q2 FY2023 | Jun 30, 2023 | $8.87M | +510.6% |
| Q1 FY2023 | Mar 31, 2023 | $10.46M | – |
| Q4 FY2022 | Dec 31, 2022 | $12.18M | – |
| Q3 FY2022 | Sep 30, 2022 | $14.06M | – |
| Q4 FY2021 | Dec 31, 2021 | $1.45M | – |